MedTech News
.................... by Andrew Celentano
Machine learning can predict preeclampsia by week 34 of pregnancy
A machine-learning model developed by Weill Cornell Medicine investigators may provide clinicians with an early warning of a complication that can occur late in pregnancy.
mRNA therapy restores fertility in genetically infertile mice
Researchers have found that targeted delivery of messenger RNA (mRNA) can restore sperm production and fertility in genetically infertile male mice.
Study points to potential new therapies for hard-to-treat lung cancers
Findings from a study led by researchers at The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) support the potential of new therapies that could improve clinical outcomes for patients with squamous and adenocarcinoma non-small cell lung cancers (NSCLC) that don’t respond to immunotherapy.
Early detection of brain disorders with a single drop of saliva
A team of Korean researchers has, for the first time, developed a technology capable of enabling early diagnosis of major neurological disorders including epilepsy, Parkinson’s disease, and schizophrenia using only a small amount of saliva
Overcoming ovarian cancer’s resistance to immunotherapy
Scientists at Sanford Burnham Prebys and the University of California San Diego have published findings in Cell Reports demonstrating a treatment approach in mice that allowed more tumor-fighting cells to approach tumors.
For the First Time, Lab‑Grown Brain Organoids Display Ability to Learn
Learn more about the advances in brain organoids and what this science could mean for the future.
New insights into a hidden process that protects cells from harmful mutations
Research reveals how cells may activate a compensation system that can reduce the effects of harmful genetic mutations. This could inform gene therapy development.
Bayer secures expanded FDA clearances for MRI contrast agent injector
The FDA’s expanded clearances broaden the application of Bayer’s Medrad MRXperion system across a wider range of MR settings.